Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.
第一作者:
Toru,Usui
第一单位:
Pharmacokinetics Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.
作者:
主题词
细胞色素P450酶系统(Cytochrome P-450 Enzyme System);剂量效应关系, 药物(Dose-Response Relationship, Drug);葡糖醛酸(Glucuronic Acid);葡糖醛酸基转移酶(Glucuronosyltransferase);谷胱甘肽(Glutathione);肝细胞(Hepatocytes);人类(Humans);肝(Liver);代谢组学(Metabolomics);微粒体, 肝(Microsomes, Liver);NADP(NADP);蛋白质结合(Protein Binding);结果可重复性(Reproducibility of Results);危险性评估(Risk Assessment);危险因素(Risk Factors)
DOI
10.1124/dmd.109.028860
PMID
19720731
发布时间
2025-02-12
- 浏览56
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文